cibenzoline
DISEASE INTERVENTION COMPARISON RESULTS
J Clin Pharmacol. 1995 May;35(5):471-7 Randomized Controlled Trial
IN StudyID: Babuty 1999 (subordinated publication), atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Ann Cardiol Angeiol (Paris). 1997 Feb;46(2):109-16 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Babuty 1999 (subordinated publication), atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Annals of Noninvasive Electrocardiology. 1999;4(1):53-59 Randomized Controlled Trial
IN StudyID: Babuty 1999, atrial fibrillation, paroxysmal The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
flecainide
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Arch Mal Coeur Vaiss. 1985 Oct; 78 Spec No: 99-103 Randomized Controlled Trial
IN StudyID: Frances 1985, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
quinidine
To AF recurrences, adverse effects - at 6 months
Ann Cardiol Angeiol (Paris). 1996 Oct;45(8):469-79 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Lardoux 1996, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
propafenone
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Arch Mal Coeur Vaiss. 1998 Dec;91(12):1481-6 Randomized Controlled Trial, Multicenter Trial
IN StudyID: Piot 1998, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
disopyramide
To AF recurrence, adverse effects - at 6 months
Ann Cardiol Angeiol (Paris). 1995 Nov;44(9):525-31 Randomized Controlled Trial
IN StudyID: Touboul 1996, atrial fibrillation The Use of
cibenzoline
As Treatment, Chronic
Is equal Than
quinidine
To AF recurrence, adverse effects, pro-arrhythmia - at 6 months